{
    "2018-07-05": [
        [
            {
                "time": "2018-07-12",
                "original_text": "AbbVie wins reversal of $140 mln verdict in case over AndroGel risks",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "reversal",
                        "verdict",
                        "AndroGel"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-07-12",
                "original_text": "U.S. judge tosses $140 mln verdict against AbbVie in AndroGel case",
                "features": {
                    "keywords": [
                        "U.S.",
                        "judge",
                        "tosses",
                        "verdict",
                        "AbbVie",
                        "AndroGel"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-07-12",
                "original_text": "Here's Why AbbVie Stock is Good for Your Portfolio's Health",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Stock",
                        "Portfolio",
                        "Health"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-12",
                "original_text": "A Look At Biotech In 2018 And The Biggest Catalysts Coming Up In The Second Half Of The Year",
                "features": {
                    "keywords": [
                        "Biotech",
                        "Catalysts",
                        "Second Half",
                        "Year"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-12",
                "original_text": "If You Like Dividends, You Should Love These 3 Stocks",
                "features": {
                    "keywords": [
                        "Dividends",
                        "Stocks"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-12",
                "original_text": "[$$] AbbVie Director Makes Biggest-Ever Insider Stock Buy",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Director",
                        "Insider",
                        "Stock",
                        "Buy"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-07-12",
                "original_text": "FOCUS-Drugmakers try evasion, tougher negotiations to fight new U.S. insurer tactic",
                "features": {
                    "keywords": [
                        "Drugmakers",
                        "evasion",
                        "negotiations",
                        "U.S.",
                        "insurer",
                        "tactic"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}